BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT04736706-completion@plaintrial.com
DTSTAMP:20261028T061609Z
DTSTART;VALUE=DATE:20261029
SUMMARY:A Study of Pembrolizumab (MK-3475) in Combination With Belzutifan (
 MK-6482) and Lenvatinib (MK-7902)\, or Pembrolizumab/Quavonlimab (MK-1308A
 ) in Combination With Lenvatinib\, Versus Pembrolizumab and Lenvatinib\, f
 or Treatment of Advanced Clear Cell Renal Cell Carcinoma (MK-6482-012) —
  estimated completion date
DESCRIPTION:Active\, not recruiting. Saved on your PlainTrial shortlist. Fu
 ll trial record: https://plaintrial.com/trial/NCT04736706
URL:https://plaintrial.com/trial/NCT04736706
END:VEVENT
END:VCALENDAR